Compared with healthy controls, serum levels of GDF-15, a member of the TGF-β superfamily, were remarkably upregulated in mCRC patients and had the same sensitivity as the standard tumor marker CEA, indicating that GDF-15 could be an effective biomarker in mCRC patients [162]. Here, GDF15 is linked to neoplasm.